MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate

Clinical trial NCT02067143 · COMPLETED

Trial details

NCT number: NCT02067143
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Untreated Philadelphia Positive Acute Lymphoblastic Leukemia De Novo Secondary Low-dose Corticosteroids Pretreatment

Start date: 2014-05-20
Primary completion: 2016-10-07
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.